- Report
- April 2026
- 180 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- May 2026
- 350 Pages
Global
From €4632EUR$4,949USD£3,872GBP
- Report
- May 2026
- 350 Pages
Global
From €4632EUR$4,949USD£3,872GBP
- Report
- May 2026
- 150 Pages
Global
From €2610EUR$2,789USD£2,182GBP
- Report
- May 2026
- 350 Pages
Global
From €4632EUR$4,949USD£3,872GBP
- Report
- May 2026
- 400 Pages
Global
From €4632EUR$4,949USD£3,872GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2610EUR$2,789USD£2,182GBP
- Report
- May 2026
- 150 Pages
Global
From €2526EUR$2,699USD£2,112GBP
- Report
- May 2026
- 283 Pages
Global
From €2340EUR$2,500USD£1,956GBP
- Report
- February 2026
- 288 Pages
Global
From €2340EUR$2,500USD£1,956GBP
- Report
- April 2026
- 188 Pages
Global
From €7478EUR$7,990USD£6,251GBP
- Report
- April 2026
- 137 Pages
Global
From €3743EUR$3,999USD£3,129GBP
- Report
- July 2026
- 200 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- July 2026
- 120 Pages
Global
From €4446EUR$4,750USD£3,716GBP
- Report
- July 2026
- 150 Pages
Global
From €3510EUR$3,750USD£2,934GBP
- Report
- May 2026
- 350 Pages
Global
From €4632EUR$4,949USD£3,872GBP
- Report
- May 2026
- 400 Pages
Global
From €4632EUR$4,949USD£3,872GBP
- Report
- May 2026
- 155 Pages
Global
From €3697EUR$3,950USD£3,090GBP
- Report
- May 2026
- 148 Pages
Global
From €3697EUR$3,950USD£3,090GBP
- Report
- May 2026
- 152 Pages
Global
From €3697EUR$3,950USD£3,090GBP

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient.
Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more